Rhythm Pharmaceuticals (RYTM) Shares Issued: 2017-2025
Historic Shares Issued for Rhythm Pharmaceuticals (RYTM) over the last 4 years, with Sep 2025 value amounting to -$22.9 million.
- Rhythm Pharmaceuticals' Shares Issued fell 537.37% to -$22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.5 million, marking a year-over-year decrease of 30.21%. This contributed to the annual value of $39.1 million for FY2024, which is 19.91% down from last year.
- According to the latest figures from Q3 2025, Rhythm Pharmaceuticals' Shares Issued is -$22.9 million, which was down 167.22% from $34.0 million recorded in Q1 2025.
- Over the past 5 years, Rhythm Pharmaceuticals' Shares Issued peaked at $161.7 million during Q1 2021, and registered a low of -$22.9 million during Q3 2025.
- Its 3-year average for Shares Issued is $11.0 million, with a median of $5.2 million in 2024.
- Its Shares Issued has fluctuated over the past 5 years, first spiked by 282,860.00% in 2022, then tumbled by 537.37% in 2025.
- Quarterly analysis of 5 years shows Rhythm Pharmaceuticals' Shares Issued stood at -$5,000 in 2021, then soared by 282,860.00% to $14.1 million in 2022, then slumped by 58.84% to $48.0 million in 2023, then tumbled by 89.10% to $26.2 million in 2024, then tumbled by 537.37% to -$22.9 million in 2025.
- Its Shares Issued was -$22.9 million in Q3 2025, compared to $34.0 million in Q1 2025 and $26.2 million in Q4 2024.